AVITA Medical Announces Management Changes and Fourth Quarter 2022 Earnings Conference CallGlobeNewsWire • 01/19/23
AVITA Medical Submits FDA PMA Supplement to Further Expand Indication to Soft Tissue RepairGlobeNewsWire • 12/12/22
AVITA Medical® to Present at the Piper Sandler 34th Annual Healthcare ConferenceGlobeNewsWire • 11/21/22
Wall Street Analysts See a 127% Upside in Avita Medical Inc. (RCEL): Can the Stock Really Move This High?Zacks Investment Research • 11/15/22
AVITA Medical Announces Achievement of Co-Primary Endpoints in Updated Analysis of Pivotal Trial of RECELL® System for Soft Tissue RepairGlobeNewsWire • 11/09/22
AVITA Medical Announces FDA Breakthrough Device Designations for the RECELL® SystemGlobeNewsWire • 11/04/22
AVITA Medical Appoints Industry Leader James Corbett as Chief Executive OfficerGlobeNewsWire • 09/28/22
AVITA Medical Achieves Positive Topline Pivotal Trial Results for Treatment of Stable Vitiligo Using the RECELL® SystemGlobeNewsWire • 09/12/22
RECELL® System Data to be Presented at the Controversies and Conversations in Laser & Cosmetic Surgery Annual MeetingGlobeNewsWire • 08/17/22
AVITA Medical, Inc. (RCEL) CEO Dr. Mike Perry on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/12/22
Does Avita Medical Inc. (RCEL) Have the Potential to Rally 210% as Wall Street Analysts Expect?Zacks Investment Research • 06/07/22
AVITA Medical, Inc. (RCEL) CEO Mike Perry on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/13/22
RECELL® System to be Highlighted at Upcoming Music City SCALE Multidisciplinary Dermatology MeetingGlobeNewsWire • 05/09/22